Creative Planning Portfolio holdings
AUM
$117B
1-Year Return
13.67%
This Quarter Return
-0.75%
1 Year Return
+13.67%
3 Year Return
+45.97%
5 Year Return
+68.1%
10 Year Return
+115.56%
AUM
$106B
AUM Growth
+$3.52B
(+3.4%)
Cap. Flow
+$4.99B
Cap. Flow
% of AUM
4.69%
Top 10 Holdings %
Top 10 Hldgs %
45.26%
Holding
3,766
New
210
Increased
2,148
Reduced
969
Closed
340
Top Buys
| 1 |
SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$652M |
| 2 |
Vanguard Total Bond Market
BND
|
+$587M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$336M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$283M |
| 5 |
Dimensional US Small Cap ETF
DFAS
|
+$214M |
Top Sells
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$251M |
| 2 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$91.1M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$61.6M |
| 4 |
Apple
AAPL
|
+$26.6M |
| 5 |
SPDR Portfolio Emerging Markets ETF
SPEM
|
+$22.6M |
Sector Composition
| 1 | Technology | 6.35% |
| 2 | Financials | 3.91% |
| 3 | Consumer Discretionary | 1.87% |
| 4 | Healthcare | 1.85% |
| 5 | Communication Services | 1.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2976
WSFS Financial
WSFS
$3.13B
| $221K | ﹤0.01% |
+4,264
| New | +$221K |
|
2977
Helen of Troy
HELE
$554M
| $220K | ﹤0.01% |
4,118
-1,184
| -22% | -$63.3K |
|
2978
Encore Capital Group
ECPG
$1.02B
| $220K | ﹤0.01% |
6,422
-439
| -6% | -$15K |
|
2979
Ichor Holdings
ICHR
$579M
| $220K | ﹤0.01% |
9,735
-7,214
| -43% | -$163K |
|
2980
Cass Information Systems
CASS
$565M
| $220K | ﹤0.01% |
5,083
-1,129
| -18% | -$48.8K |
|
2981
ODP
ODP
$624M
| $220K | ﹤0.01% |
+15,338
| New | +$220K |
|
2982
iShares US Insurance ETF
IAK
$715M
| $219K | ﹤0.01% |
1,591
-120
| -7% | -$16.5K |
|
2983
PureCycle Technologies
PCT
$2.4B
| $218K | ﹤0.01% |
31,559
+4,520
| +17% | +$31.3K |
|
2984
AllianzIM U.S. Large Cap Buffer20 May ETF
MAYW
$78.1M
| $218K | ﹤0.01% |
+7,128
| New | +$218K |
|
2985
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$409M
| $218K | ﹤0.01% |
2,939
+64
| +2% | +$4.76K |
|
2986
SITE Centers
SITC
$463M
| $218K | ﹤0.01% |
16,977
+182
| +1% | +$2.34K |
|
2987
Iovance Biotherapeutics
IOVA
$821M
| $217K | ﹤0.01% |
65,188
+1,808
| +3% | +$6.02K |
|
2988
iShares Core Moderate Allocation ETF
AOM
$1.61B
| $217K | ﹤0.01% |
4,944
-358
| -7% | -$15.7K |
|
2989
Arbutus Biopharma
ABUS
$855M
| $217K | ﹤0.01% |
62,089
+13,745
| +28% | +$48K |
|
2990
Heron Therapeutics
HRTX
$193M
| $217K | ﹤0.01% |
+98,452
| New | +$217K |
|
2991
Inter&Co
INTR
$3.93B
| $216K | ﹤0.01% |
39,392
-575
| -1% | -$3.15K |
|
|
PEO
2992
Adams Natural Resources Fund
PEO
$580M
| $216K | ﹤0.01% |
9,463
-50
| -0.5% | -$1.14K |
|
2993
Novavax
NVAX
$1.3B
| $216K | ﹤0.01% |
33,657
-6,065
| -15% | -$38.9K |
|
2994
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$111M
| $216K | ﹤0.01% |
4,520
+9
| +0.2% | +$429 |
|
2995
iShares US Tech Breakthrough Multisector ETF
TECB
$448M
| $215K | ﹤0.01% |
4,402
+482
| +12% | +$23.6K |
|
2996
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$701M
| $215K | ﹤0.01% |
+4,873
| New | +$215K |
|
2997
GMO US Quality ETF
QLTY
$2.51B
| $215K | ﹤0.01% |
+6,874
| New | +$215K |
|
|
OKLO
2998
Oklo
OKLO
$12.2B
| $214K | ﹤0.01% |
+9,913
| New | +$214K |
|
|
ALX
2999
Alexander's
ALX
$1.25B
| $214K | ﹤0.01% |
1,024
-54
| -5% | -$11.3K |
|
3000
Myriad Genetics
MYGN
$674M
| $214K | ﹤0.01% |
24,119
+24,050
| +34,855% | +$213K |
|